Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis

Journal of Clinical Psychiatry

Volumn 62, Issue 3, 2001, Pages 191-198

  Czekalla, J ^a   Beasley C M , Jr ^a   Dellva, M A ^a   Berg, P H ^a   Grundy, S ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; OLANZAPINE; PIMOZIDE; PLACEBO; RISPERIDONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

EID: 0035062824     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0310     Document Type: Article

References (52)

1. Safety of olanzapine
2. The relationship of pharmacology to side effects
3. Torsades de pointes with T wave altemans in a patient receiving moderate dose of chlorpromazine: Report of a case
4. Iatrogenic torsade de pointes induced by thioridazine
5. Torsades de pointes and low-dose haloperidol
6. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: A review of the literature
7. Fatal cardiac event following initiation of risperidone therapy
8. Torsades de pointes associated with intravenous haloperidol in critically ill patients
9. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia
10. Electrocardiographic changes in patients receiving neuroleptic medication
11. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics
12. Antipsychotic agents and QT changes
13. An analysis of the time relations of electrocardiograms
14. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes
15. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes
16. Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia
17. How to measure the QT interval: What is normal?
18. Cardiovascular effects of antidepressant drugs: Updated
19. Abnormalities of the QT interval in primary autonomic failure
20. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
21. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
22. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
23. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
24. Establishment and use of reference values
25. Laboratory tests in clinical trials interpretation of results
26. Variability of the QTc interval: Impact on defining drug effect and low-frequency cardiac event
27. Naturalistic study of olanzapine in treatment-resistant schizophrenia and acute mania, depression and obsessional disorder
28. Intoxication with olanzapine
29. Olanzapine overdose in an 18-month-old child
30. Olanzapine overdose with serum concentrations
31. Olanzapine overdose mimicking opioid intoxication
32. Olanzapine pediatric overdose
33. Olanzapine overdose
34. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
35. Olanzapine overdose in a 1-year-old male
36. Olanzapine-related fatality
37. Olanzapine overdose cause of acute extrapyramidal symptoms
38. Olanzapine overdose
39. Fatal overdose of olanzapine
40. Accidental olanzapine overdose in a child
41. Acute olanzapine overdose
42. Overdose and death with olanzapine
43. Overdose profiles of new antipsychotic agents
44. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs
45. Long QT interval syndrome: A new look at an old electrocardiographic measurement - The power of the computer
46. QT interval prolongation as predictor of sudden death in patients with myocardial infarction
47. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
48. Association between QT interval and coronary disease in middle-aged and elderly men: The Zutphen study
49. QTc dispersion predicts cardiac mortality in the elderly: The Rotterdam Study
50. Dose-response relationship between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability
51. Rate-corrected QT interval: Techniques and limitations